A longitudinal study published in JAMA Network Open on June 17, 2026, by Michigan State University researchers identifies a significant correlation between the use of combined oral contraceptives and increased emotional eating. By tracking 422 women over 49 days, the study compared eating behaviors during active hormone pill days versus inactive placebo days, revealing that synthetic estrogen and progestin exposure may trigger binge-related symptoms in some individuals. The research highlights that while hormonal contraceptives are effective for pregnancy prevention, their systemic impact on mood and behavior warrants closer clinical attention. The authors emphasize that these findings do not suggest universal risk, but rather point to a specific vulnerability in certain women, potentially those with pre-existing risk factors for eating disorders. A critical finding of the study is the efficacy of self-monitoring as a behavioral intervention. Participants who tracked their daily eating symptoms reported lower levels of binge-related behavior, even while taking active hormone pills, suggesting that awareness and documentation can serve as a protective mechanism against emotional overeating. Medical professionals are encouraged to integrate these findings into personalized care plans for patients using hormonal birth control. By educating users on potential side effects and promoting self-monitoring practices, providers can better manage the psychological well-being of women using combined oral contraceptives.
